-
1
The Potential of MicroRNAs as Novel Biomarkers for Transplant Rejection
Published 2017-01-01Get full text
Article -
2
Advancements in noninvasive techniques for transplant rejection: from biomarker detection to molecular imaging
Published 2025-02-01Subjects: “…Transplant rejection…”
Get full text
Article -
3
Pulmonary Alveolar Microlithiasis: A Unique Case of Familial PAM Complicated by Transplant Rejection
Published 2021-01-01Get full text
Article -
4
Pre-transplant T-cell clonal analysis identifies CD8+ donor reactive clones that contribute to kidney transplant rejection
Published 2025-02-01Subjects: “…kidney transplant rejection…”
Get full text
Article -
5
Immunosuppression and the Immune Response to Transplantation
Published 1993-01-01“…OBJECTIVES: To review the roles of allorecognition, transplant rejection, and immunosuppressive therapy in predisposing patients to viral infections. …”
Get full text
Article -
6
ACUTE PURULENT COMPLICATED PYELONEPHRITIS IN THE PRACTICE OF AN OBSTETRICIAN-GYNECOLOGIST (CLINICAL CASE)
Published 2024-11-01“…Acute purulent pyelonephritis in pregnant women is characterized by severe kidney damage, often leading to intoxication, sepsis, obstructive pyelonephritis, emphysematous pyelonephritis, perinephric abscess, kidney transplant rejection and death. At the same time, the issues of prevention, diagnostics and differential diagnostics of the stages of the disease are far from being resolved. …”
Get full text
Article -
7
Saving Death: Apoptosis for Intervention in Transplantation and Autoimmunity
Published 2006-01-01“…Here, we review the relationship between apoptotic cells, DCs, and Tregs, and its impact on prevention of transplant rejection and treatment of autoimmune diseases.…”
Get full text
Article -
8
Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas
Published 2013-01-01“…Everolimus is an inhibitor of the mammalian target of rapamycin (mTOR) and has been shown to have antineoplastic activity in addition to its use as an immunosuppressive agent for the prevention of organ transplant rejection. We report the use of everolimus for the compassionate treatment of four elderly, nontransplant patients presenting with multiple basal cell carcinomas (BCC). …”
Get full text
Article -
9
A Knotless Technique for Kidney Transplantation in the Mouse
Published 2012-01-01“…Mouse models of kidney transplantation are important to study molecular mechanisms of organ transplant rejection as well as to develop new therapeutic strategies aimed at improving allograft survival. …”
Get full text
Article -
10
Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation
Published 2012-01-01“…Mesenchymal stem cells (MSCs) show promise as an immunomodulatory therapeutic agent and are currently being tested in preclinical and clinical settings as therapies for autoimmune disorders or transplant rejection. The mechanisms by which MSCs modulate the immune response are still under thorough investigation, but these most likely involve expression of local factors influencing T-cell regulation, modulation of cytokine expression (e.g., IL-10, TGF-β, TNF-, INF-γ, etc.), and interactions with dendritic or antigen presenting cells. …”
Get full text
Article -
11
Regulatory T Cells in the Immunodiagnosis and Outcome of Kidney Allograft Rejection
Published 2013-01-01“…Many studies have been performed in order to define the role of Tregs either in the immunodiagnosis of transplant rejection or as predictor of the clinical outcome. …”
Get full text
Article -
12
Acute graft-versus-host disease: a case report
Published 2025-01-01“…No new lesions or liver transplant rejection occurred during 4-month follow-up.…”
Get full text
Article -
13
Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with Rituximab
Published 2014-01-01“…Eight years after the transplantation, while taking combined immunosuppressive therapy with tacrolimus and azathioprine indicated for the prevention against transplant rejection, she developed a Henoch-Schönlein purpura. …”
Get full text
Article -
14
Mucosal Epithelial Jak Kinases in Health and Diseases
Published 2021-01-01“…A selective Jak3 inhibitor CP-690550 (Xeljanz) approved by the FDA for certain chronic inflammatory conditions demonstrates immunosuppressive activity in rheumatoid arthritis, psoriasis, and organ transplant rejection. Here, we also focus on the consequences of Jak3-directed drugs on adverse effects in light of recent discoveries in mucosal epithelial functions of Jak3 with some information on other Jaks. …”
Get full text
Article -
15
Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management
Published 2018-01-01“…Thyroiditis was characterised by a brief asymptomatic hyperthyroid phase followed by a symptomatic hypothyroid phase requiring thyroxine replacement. Transplant rejection doses of methylprednisolone were necessary to manage refractory hepatotoxicity. …”
Get full text
Article -
16
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
Published 2025-02-01“…This immune-based combination was safe in terms of treatment-related adverse events, and absence of severe post-transplant rejection or graft loss. These preliminary results could pave the way for expanding transplant eligibility criteria in patients at more advanced HCC stages. …”
Get full text
Article -
17
Profiling the Resident and Infiltrating Monocyte/Macrophages during Rejection following Kidney Transplantation
Published 2020-01-01“…Other than antibody and T cell-mediated immune rejection, macrophage-mediated innate immunity plays an important role in the onset phase of transplantation rejection. However, due to the complexity of the kidney environment as well as its diversity and low abundance, studies pertaining to monocyte/macrophages in kidney transplantation require further elucidation. …”
Get full text
Article -
18
Protective Effect of CXCR3+CD4+CD25+Foxp3+ Regulatory T Cells in Renal Ischemia-Reperfusion Injury
Published 2015-01-01“…Regulatory T cells (Tregs) suppress excessive immune responses and are potential therapeutic targets in autoimmune disease and organ transplantation rejection. However, their role in renal ischemia-reperfusion injury (IRI) is unclear. …”
Get full text
Article